Search

everythinglearnresearchcommunity

for

Search:↓

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Anti-TNF therapy can cause hair loss and skin issues.

Ixekizumab has known and some unexpected side effects.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Abrocitinib may effectively treat Lichen Planopilaris.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Apremilast showed mixed results for treating severe alopecia areata.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.